Search

Your search keyword '"Kunze-Schumacher, H"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Kunze-Schumacher, H" Remove constraint Author: "Kunze-Schumacher, H"
27 results on '"Kunze-Schumacher, H"'

Search Results

1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

2. miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity

3. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

4. Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3

5. Germline deletion reveals a non-essential role of the atypical MAPK6/ERK3

8. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

9. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

10. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).

11. Modeling the Dynamics of T-Cell Development in the Thymus.

12. The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis.

13. The Role of MicroRNAs in Development and Function of Regulatory T Cells - Lessons for a Better Understanding of MicroRNA Biology.

14. The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity.

15. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).

16. Releasing the concept of HLA-allele specific peptide anchors in viral infections: A non-canonical naturally presented human cytomegalovirus-derived HLA-A*24:02 restricted peptide drives exquisite immunogenicity.

17. Interactions in the ESCRT-III network of the yeast Saccharomyces cerevisiae.

18. miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity.

19. MicroRNA miR-181a/b-1 controls MAIT cell development.

20. miR-191 modulates B-cell development and targets transcription factors E2A, Foxp1, and Egr1.

21. miRNA miR-21 Is Largely Dispensable for Intrathymic T-Cell Development.

22. The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection.

23. Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.

24. Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.

25. HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.

26. Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.

27. A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes.

Catalog

Books, media, physical & digital resources